Zelin Hou

414 total citations
9 papers, 250 citations indexed

About

Zelin Hou is a scholar working on Oncology, Immunology and Molecular Biology. According to data from OpenAlex, Zelin Hou has authored 9 papers receiving a total of 250 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Oncology, 5 papers in Immunology and 3 papers in Molecular Biology. Recurrent topics in Zelin Hou's work include Pancreatic and Hepatic Oncology Research (6 papers), Phagocytosis and Immune Regulation (3 papers) and Immune cells in cancer (3 papers). Zelin Hou is often cited by papers focused on Pancreatic and Hepatic Oncology Research (6 papers), Phagocytosis and Immune Regulation (3 papers) and Immune cells in cancer (3 papers). Zelin Hou collaborates with scholars based in China, United States and Portugal. Zelin Hou's co-authors include Heguang Huang, Yu Pan, Fengchun Lu, Xunbin Yu, Xianchao Lin, Qinglin Fei, Xingxing Yu, Minggui Pan, Yuan Dang and Ping Xiong and has published in prestigious journals such as Nature Nanotechnology, Scientific Reports and Cell Death and Disease.

In The Last Decade

Zelin Hou

9 papers receiving 249 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Zelin Hou China 6 157 140 73 42 24 9 250
Lucas Blanchard United States 4 180 1.1× 195 1.4× 100 1.4× 28 0.7× 29 1.2× 9 307
Victoria Kim United States 4 205 1.3× 143 1.0× 85 1.2× 34 0.8× 20 0.8× 6 301
Dasa He China 5 89 0.6× 59 0.4× 92 1.3× 47 1.1× 30 1.3× 7 194
Sadaf Mehdizadeh United States 3 182 1.2× 118 0.8× 103 1.4× 40 1.0× 39 1.6× 6 298
Melissa J. Kasiewicz United States 9 239 1.5× 279 2.0× 61 0.8× 25 0.6× 36 1.5× 18 365
María Ochoa-de-Olza Spain 5 116 0.7× 62 0.4× 117 1.6× 73 1.7× 50 2.1× 7 243
Shin Takesue Japan 6 138 0.9× 60 0.4× 107 1.5× 58 1.4× 40 1.7× 11 225
Varintra E. Lander United States 5 121 0.8× 117 0.8× 79 1.1× 34 0.8× 18 0.8× 5 221
Andrew Baessler United States 5 147 0.9× 151 1.1× 67 0.9× 21 0.5× 23 1.0× 6 267
Xueliang Ding China 8 90 0.6× 82 0.6× 113 1.5× 36 0.9× 23 1.0× 10 241

Countries citing papers authored by Zelin Hou

Since Specialization
Citations

This map shows the geographic impact of Zelin Hou's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Zelin Hou with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Zelin Hou more than expected).

Fields of papers citing papers by Zelin Hou

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Zelin Hou. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Zelin Hou. The network helps show where Zelin Hou may publish in the future.

Co-authorship network of co-authors of Zelin Hou

This figure shows the co-authorship network connecting the top 25 collaborators of Zelin Hou. A scholar is included among the top collaborators of Zelin Hou based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Zelin Hou. Zelin Hou is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

9 of 9 papers shown
1.
Lin, Jiajing, Zelin Hou, Zhiyuan Wang, et al.. (2025). Annexin A1 mRNA-loaded liposomes alleviate acute pancreatitis by suppressing STING pathway and promoting efferocytosis in macrophages. Nature Nanotechnology. 20(10). 1514–1525. 2 indexed citations
2.
Lin, Jiajing, et al.. (2025). Annexin A1 regulates inflammatory-immune response and reduces pancreatic and extra- pancreatic injury during severe acute pancreatitis. Genes and Immunity. 26(2). 124–136. 1 indexed citations
3.
Chen, Zhijiang, et al.. (2024). The prognostic and therapeutic value of the tumor microenvironment and immune checkpoints in pancreatic neuroendocrine neoplasms. Scientific Reports. 14(1). 24669–24669. 4 indexed citations
4.
Hou, Zelin, Fengchun Lu, Jiajing Lin, et al.. (2024). Loss of Annexin A1 in macrophages restrains efferocytosis and remodels immune microenvironment in pancreatic cancer by activating the cGAS/STING pathway. Journal for ImmunoTherapy of Cancer. 12(9). e009318–e009318. 11 indexed citations
5.
Pan, Yu, Jiajing Lin, Zelin Hou, et al.. (2023). High-dimensional single-cell analysis unveils distinct immune signatures of peripheral blood in patients with pancreatic ductal adenocarcinoma. Frontiers in Endocrinology. 14. 1181538–1181538. 6 indexed citations
6.
Hou, Zelin, Jiajing Lin, Zhijiang Chen, et al.. (2023). Single-cell RNA sequencing revealed subclonal heterogeneity and gene signatures of gemcitabine sensitivity in pancreatic cancer. Frontiers in Pharmacology. 14. 1193791–1193791. 13 indexed citations
7.
Hou, Zelin, Yu Pan, Qinglin Fei, et al.. (2020). Prognostic significance and therapeutic potential of the immune checkpoint VISTA in pancreatic cancer. Journal of Cancer Research and Clinical Oncology. 147(2). 517–531. 47 indexed citations
8.
Fei, Qinglin, Yu Pan, Yuanyuan Zhou, et al.. (2020). High-dimensional single-cell analysis delineates radiofrequency ablation induced immune microenvironmental remodeling in pancreatic cancer. Cell Death and Disease. 11(7). 589–589. 45 indexed citations
9.
Pan, Yu, Fengchun Lu, Qinglin Fei, et al.. (2019). Single-cell RNA sequencing reveals compartmental remodeling of tumor-infiltrating immune cells induced by anti-CD47 targeting in pancreatic cancer. Journal of Hematology & Oncology. 12(1). 124–124. 121 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026